Medical Australia Limited
Print Page
Archived ASX Announcements
20-Nov-2017
LODGMENT OF COURT ORDERS WITH ASIC
20-Nov-2017
Suspension from Official Quotation (COB 20/11/2017)
17-Nov-2017
COURT APPROVES SCHEME OF ARRANGEMENT
15-Nov-2017
Substituted annexure to announcement re Scheme Meeting
15-Nov-2017
AMENDED ANNEXURE TO ANNOUNCEMENT RE SCHEME MEETING
15-Nov-2017
MLA SHAREHOLDERS APPROVE SCHEME
19-Oct-2017
Appendix 4C - quarterly
13-Oct-2017
2017 Annual General Meeting - Advice of ASIC Relief
13-Oct-2017
DISPATCH OF SCHEME BOOKLET TO SHAREHOLDERS
6-Oct-2017
Scheme Booklet Registered with ASIC
4-Oct-2017
Court approves Scheme Booklet and Convening of Meeting
27-Sep-2017
APPENDIX 4G
27-Sep-2017
Annual Report to shareholders
14-Sep-2017
Scheme Of Arrangement Update
30-Aug-2017
APPENDIX 4E AND PRELIMINARY FINAL REPORT
10-Aug-2017
MLA & ICU MEDICAL INC SIGNS SCHEME IMPLEMENTATION AGREEMENT
26-Apr-2017
Appendix 4C March 2017 Quarter
28-Feb-2017
Half Yearly Report and Accounts
22-Feb-2017
Ardo Breast Pump Agreement
15-Feb-2017
Change in substantial holding
10-Feb-2017
Product Update
7-Feb-2017
Change in substantial holding
31-Jan-2017
Quarterly Report
31-Jan-2017
Appendix 4C - quarterly
27-Jan-2017
Change in substantial holding
28-Nov-2016
Results of Meeting
31-Oct-2016
Quarterly Report
31-Oct-2016
Appendix 4C - quarterly
21-Oct-2016
Notice of Annual General Meeting
30-Sep-2016
Appendix 4G
30-Sep-2016
Annual Report 2016
31-Aug-2016
Preliminary Final Report
18-Aug-2016
Change in substantial holding
29-Jul-2016
Appendix 4C - quarterly
29-Jul-2016
Quarterly Cashflow Report
30-May-2016
Change of Share Registry address
17-May-2016
Distribution Agreement with Ardo
5-May-2016
Change in substantial holding
4-May-2016
Change in substantial holding
13-Apr-2016
Appendix 4C and Commentary
29-Feb-2016
Medical Australia Limited Interim Financial Report
10-Feb-2016
Response to ASX Appendix 4C Query
8-Feb-2016
Exclusive Distribution Rights for DuelCap System Secured
29-Jan-2016
Appendix 4C - 31 December 2015
29-Jan-2016
Quarterly Report - December 2015
22-Dec-2015
MLA Finalises Sale of MediVet
23-Nov-2015
Release of Restricted Securities from Voluntary Escrow
13-Nov-2015
Medivet Biologics US Animal Health Business
13-Nov-2015
Results of Annual General Meeting
13-Oct-2015
Notice of AGM & Explanatory Memorandum
30-Sep-2015
Appendix 4G
30-Sep-2015
Annual Report 2015
31-Aug-2015
Revenue Report for Year Ended 30 June 2015
31-Aug-2015
Appendix 4E - 30 June 2015
31-Jul-2015
Appendix 4C - 30 June 2015
31-Jul-2015
Quarterly Report - 30 June 2015
10-Jul-2015
Change of Share Registry Name
23-Jun-2015
Focus on Human Healthcare & Dilution of Animal Business
30-Apr-2015
Appendix 4C - 31 March 2015
30-Apr-2015
Quarterly Report - 31 March 2015
20-Mar-2015
Notice of Change of Interests of Substantial Holde
20-Mar-2015
Form 603 - Notice of Initial Substantial Holder
10-Mar-2015
Terms of Incentive Share Scheme - CEO
27-Feb-2015
Half Yearly Commentary
27-Feb-2015
Half Year Report for Period Ended 31 December 2014
30-Jan-2015
Quarterly Report and Appendix 4C - 31 December 2014
21-Jan-2015
Updated Contact Details for Share Registry
19-Jan-2015
MLA Subsidiary to help Develop Canine Cancer Treatment
4-Dec-2014
Terms of Appointment of CEO
4-Dec-2014
Release of Restricted Securities from Voluntary Escrow
2-Dec-2014
Darryl Ellis appointed as CEO of Medical Australia Limited
21-Nov-2014
Release of Restricted Securities from Voluntary Escrow
14-Nov-2014
Notice of Initial Substantial Holder - Pie Funds Management
14-Nov-2014
Becoming a substantial holder
13-Nov-2014
Change in substantial holding
13-Nov-2014
Change in substantial holding notices
12-Nov-2014
Notice in Accordance with the Corporations Act 2001
12-Nov-2014
Amended Number of Shares Issued Pursuant to Rights Issue
12-Nov-2014
Further Amended Notification of Under-Subscriptions
10-Nov-2014
Shares Listed Pursuant to Non-Renounceable Rights Issue
10-Nov-2014
Amended Notification of Under-Subscriptions - Rights Issue
7-Nov-2014
Appendix 3Y - Ian Mitchell
7-Nov-2014
Notification of Under-Subscriptions - Rights Issue
6-Nov-2014
Results of Annual General Meeting
28-Oct-2014
Appendix 4C - 30.9.14
28-Oct-2014
Quarterly Report - September 2014
14-Oct-2014
Non-Renounceable Rights Issue Offer Document
14-Oct-2014
Appendix 3B
13-Oct-2014
Notice of Intention to Offer a Rights Issue
13-Oct-2014
Letter to All Shareholders - Rights Issue
3-Oct-2014
Notice of Annual General Meeting
30-Sep-2014
Annual Report 2014
29-Aug-2014
Appendix 4E - 30 June 2014
27-Aug-2014
Retirement of Chairman
25-Aug-2014
Appendix 3B
4-Aug-2014
MLA Appoints Dr Amy Crouch as National Veterinary Manager
30-Jul-2014
Quarterly Report - 30 June 2014
30-Jul-2014
Appendix 4C
7-Jul-2014
MediVet Successful in out of Court Settlement
3-Jul-2014
MLA licensed for distribution of nanofiber animal technology
1-Jul-2014
Appendix 3Y- Mitchell
19-Jun-2014
Appendix 3Y- Mitchell
14-May-2014
Appendix 3B
30-Apr-2014
Quarterly Report & Appendix 4C - March 2014
28-Feb-2014
Appendix 4D & Half-Yearly Report
28-Feb-2014
Appendix 3X - Jeremy Delk
28-Feb-2014
Appointment of Jeremy Delk as a Director
19-Feb-2014
Change of Share Registry
14-Feb-2014
Amended Appendix 3X
14-Feb-2014
Amendment to Announcement Dated 13 February 2014
13-Feb-2014
Appendix 3X - Hancox
13-Feb-2014
Appendix 3Z - Donnison
13-Feb-2014
Board and Management Changes
11-Feb-2014
Notice of Initial Substantial Holder
31-Jan-2014
Quarterly Report December 2013
31-Jan-2014
Appendix 4C
16-Jan-2014
Response to ASX Price Query Letter
16-Dec-2013
Change in substantial holding
12-Dec-2013
Becoming a substantial holder
12-Dec-2013
Becoming a substantial holder
12-Dec-2013
Becoming a substantial holder
12-Dec-2013
Becoming a substantial holder
12-Dec-2013
Becoming a substantial holder
10-Dec-2013
MLA Raises $4 Million To Fast Track Growth
10-Dec-2013
Appendix 3B
5-Dec-2013
Appendix 3B
29-Nov-2013
Results of Annual General Meeting
22-Nov-2013
Change of Principal Place of Business
29-Oct-2013
Notice to Shareholders
29-Oct-2013
Notice of Annual General Meeting
25-Oct-2013
Appendix 4C
30-Sep-2013
Annual Report 2013
24-Sep-2013
MLA signs agreement to acquire MediVet
30-Aug-2013
Appendix 4E
19-Aug-2013
Appendix 3Y - Mitchell
31-Jul-2013
Appendix 4C - Quarter June 2013
16-Jul-2013
Amended Results of General Meeting - 15 July 2013
16-Jul-2013
Results of General Meeting - 15 July 2013
25-Jun-2013
Consolidation of Shares Proposal - Amended Timetable
20-Jun-2013
Amended Appendix 3Y - Donnison
13-Jun-2013
Investor Presentation
12-Jun-2013
Independent Expert's Report
12-Jun-2013
Notice of General Meeting and Explanatory Memorandum
11-Jun-2013
Appendix 3Y
11-Jun-2013
Appendix 3Y
6-Jun-2013
MLA Announces Acquisition of Medivet
30-Apr-2013
Amended Appendix 4C
30-Apr-2013
Appendix 4C
22-Apr-2013
MLA Expands OEM Agreements
12-Mar-2013
MLA strengthens UK presence with NHS Trust Supply Agreement
28-Feb-2013
Half Year Report
12-Feb-2013
Response to ASX Query - Appendix 4C
30-Jan-2013
Appendix 4C
15-Nov-2012
Update on Sales and Marketing of FirstFlow Burette
8-Nov-2012
Results of Annual General Meeting
26-Oct-2012
Appendix 4C
8-Oct-2012
Notice of Annual General Meeting
8-Oct-2012
2012 Annual Report and Notice of AGM sent to Shareholders
28-Sep-2012
Annual Report 2012
31-Aug-2012
Amended Appendix 3X
28-Aug-2012
Appendix 4E
30-Jul-2012
Appendix 4C
3-Jul-2012
COMMENCEMENT OF SALES OF TUTA BURETTES WITH MEDIAFLUSH tm
22-Jun-2012
Appendix 3Y
18-Jun-2012
Appendix 3Y
1-May-2012
Appendix 3B
30-Apr-2012
MLA successfully completes first animal stem cell treatment
30-Apr-2012
Appendix 4C
5-Apr-2012
BRR Interview
3-Apr-2012
MLA first in Europe to cryogenically freeze stem cells
28-Feb-2012
Appendix 4D
25-Jan-2012
Appendix 4C
23-Jan-2012
Update to independent research report on MLA
10-Jan-2012
Appendix 3X
10-Jan-2012
Appointment of Chairman
5-Dec-2011
Appendix 3Z
30-Nov-2011
Death of Chairman of the Company
22-Nov-2011
MLA secures over $1.5 million in new supply agreements
14-Nov-2011
Boardroom Radio Webcast
11-Nov-2011
Change of Share Registry
8-Nov-2011
Results of Annual General Meeting
27-Oct-2011
MLA reports first quarter revenue of $3 million
27-Oct-2011
Appendix 4C
7-Oct-2011
Annexure to Notice of Annual General Meeting
7-Oct-2011
Notice of Annual General Meeting
7-Oct-2011
Notice to Shareholders - Annual Report and AGM
6-Oct-2011
Share Trading Policy
4-Oct-2011
Share Trading Policy
30-Sep-2011
Annual Report
30-Sep-2011
MLA launches American Depositary Receipt Program
5-Sep-2011
Appendix 3B
1-Sep-2011
Boardroom Radio Broadcast
23-Aug-2011
MLA secures new distribution agreement
22-Aug-2011
Appendix 4E Commentary
22-Aug-2011
Appendix 4E
25-Jul-2011
MLA well funded in cash following Option Conversion
22-Jul-2011
Appendix 4C - quarterly
19-Jul-2011
Option Issue Shortfall
19-Jul-2011
Appendix 3B
6-Jul-2011
Supply Agreement for Analytica
5-Jul-2011
Appendix 3B
5-Jul-2011
Secures Master Distributorship for MediVet in UK
1-Jul-2011
Final Director`s Interest Notice
1-Jul-2011
Initial Director`s Interest Notice
1-Jul-2011
Director Appointment/Resignation
30-Jun-2011
Change of Director`s Interest Notice
29-Jun-2011
Change of Director`s Interest Notice
28-Jun-2011
Change of Director`s Interest Notice
17-Jun-2011
Amended Appendix 3Y
17-Jun-2011
Appendix 3Y
14-Jun-2011
Appendix 3Y
9-Jun-2011
Notice to Holders
3-Jun-2011
Appointment of Underwriter
11-May-2011
New supply contract with UNICEF
10-May-2011
Independent research report on MLA
15-Apr-2011
Appendix 4C
4-Apr-2011
New supply agreement with Healthscope
28-Mar-2011
Appendix 3B
28-Mar-2011
MLA secures new distribution agreement with Haemonetics
18-Mar-2011
Appendix 3Y
11-Mar-2011
Appendix 3Y
7-Mar-2011
Appendix 3Y
24-Feb-2011
Amended Appendix 3B
23-Feb-2011
Appendix 3B
22-Feb-2011
MLA report maiden NPAT with growth continuing
22-Feb-2011
Appendix 4D
15-Feb-2011
Appendix 3Y
7-Feb-2011
Appendix 3Y
25-Jan-2011
Appendix 4C
25-Jan-2011
MLA delivers 18% increase in half year revenue to $4.6 mill
20-Jan-2011
Amended Appendix 3Y
14-Jan-2011
Appendix 3Y
12-Jan-2011
Medical Australia Limited Broadcast
11-Jan-2011
Landmark OEM agreement with leading global medical device co
24-Dec-2010
Appendix 3B
23-Dec-2010
Securities Trading Policy
25-Nov-2010
Update on Care Essentials and Placement of Shortfall
23-Nov-2010
Three year OEM supply agreement with Terumo Medical Corp
17-Nov-2010
Notice in accordance with Section 1012DA(5)(e)
17-Nov-2010
Appendix 3B
15-Nov-2010
Results of Annual General Meeting
15-Nov-2010
Presentation
10-Nov-2010
Amended Appendix 3Y
5-Nov-2010
Appendix 3Y
3-Nov-2010
Broadcast
2-Nov-2010
MLA reports record first quarter performance
26-Oct-2010
Appendix 4C
18-Oct-2010
Notice of Annual General Meeting and Proxy Form
18-Oct-2010
Notice to Shareholders
8-Oct-2010
Appendix 3Y
30-Sep-2010
Appendix 3B
30-Sep-2010
Annual Report for year ended 30 June 2010
24-Sep-2010
Appendix 3Y
21-Sep-2010
Appendix 3B
21-Sep-2010
Amended Appendix 3Y
20-Sep-2010
Appendix 3Y
7-Sep-2010
Appendix 3Y
3-Sep-2010
Appendix 3Y
3-Sep-2010
Appendix 3Y
1-Sep-2010
Update on Care Essentials Transaction
31-Aug-2010
Appendix 4E
30-Aug-2010
Appendix 3Y
24-Aug-2010
Appendix 3B
19-Aug-2010
Appendix 3Y
18-Aug-2010
Notification of Under Subscription Rights Issue
30-Jul-2010
Despatch of offers non-renounceable rights issue
29-Jul-2010
Appendix 4C
20-Jul-2010
Medical Australia Limited Broadcast
15-Jul-2010
Results of General Meeting
12-Jul-2010
MLA secures multi-million dollar global agreement - Medivet
8-Jul-2010
MLA signs contract for Care Essentials acquisition
11-Jun-2010
Notice of General Meeting
11-Jun-2010
Replacement Prospectus
7-Jun-2010
Amended Appendix 3B
7-Jun-2010
Replacement Prospectus
3-Jun-2010
Amended Appendix 3B
3-Jun-2010
Appendix 3B
3-Jun-2010
Rights Issue Prospectus
19-May-2010
Release of restricted securities from voluntary escrow
30-Apr-2010
Appendix 3Y
29-Apr-2010
Appendix 4C
28-Apr-2010
Appendix 3B
13-Apr-2010
MLA and ALT sign licensing and distribution agreement
8-Apr-2010
MLA acquires leading medical products business
26-Mar-2010
Release from Restricted Securities
15-Mar-2010
Amended Appendix 3B
12-Mar-2010
Appendix 3B
3-Mar-2010
Appendix 3Z-Mann
3-Mar-2010
Appendix 3X - Hartigan
3-Mar-2010
MLA strengthens board and senior leadership
26-Feb-2010
Appendix 4D and Half Yearly Report
18-Feb-2010
Appendix 3Y
12-Feb-2010
Appendix 3Y
28-Jan-2010
Appendix 4C
11-Dec-2009
Amended Appendix 3B
10-Dec-2009
Appendix 3B
26-Nov-2009
MLA and ALT sign Licensing and Distribution HOA
30-Oct-2009
Appendix 4C
23-Oct-2009
Change of Company Name
23-Oct-2009
Results of Annual General Meeting 23 October 2009
20-Oct-2009
BMDI Tuta Enters UK Market with 5 Year Supply Agreement
13-Oct-2009
BMDI Tuta Posts Strong First Quarter Sales
1-Oct-2009
Appendix 3B
24-Sep-2009
Online Annual Report Notice
24-Sep-2009
Notice of Annual General Meeting
24-Sep-2009
Annual Report
24-Sep-2009
2009 Annual Report and Notice of AGM Letter
1-Sep-2009
BMDI Tuta Delivers Revenue Growth
1-Sep-2009
Appendix 4E
6-Aug-2009
Response to ASX Query re Appendic 4C
31-Jul-2009
Appendix 4C - Quarterly Report - BMDI Tuta Limited
24-Jun-2009
BMDI Tuta well positioned for next stage of growth
22-Jun-2009
Notice in Accordance with Section 1012DA(5)(e)
15-Jun-2009
Appendix 3B
27-May-2009
Notice if Accordance with Section 1012DA(5)(e)
22-May-2009
Notification of under-subscriptions re Rights Issue
11-May-2009
Appendix 3Y - Cumming
30-Apr-2009
Appendix 4C
30-Apr-2009
ASX Circular: Rights Issue Timetable
29-Apr-2009
Despatch of Offer Document
27-Apr-2009
Offer Document
24-Apr-2009
REINSTATEMENT TO OFFICIAL QUOTATION
24-Apr-2009
Announcement - Rights Issue
24-Apr-2009
Appendix 3B
23-Apr-2009
Suspension from Official Quotation
21-Apr-2009
Trading Halt
31-Mar-2009
Acqusition Of Clements Medical Equipment
2-Mar-2009
Half Yearly Report Announcement
27-Feb-2009
Announcement Half Yearly
27-Feb-2009
Half Yearly Report
5-Feb-2009
Response to ASX Query regarding Appendix 4C
30-Jan-2009
Appendix 4C
28-Jan-2009
Initial Director`s Interest Notice
27-Jan-2009
Changes to Board and Management team
13-Jan-2009
Change of Director`s Interest Notice
2-Dec-2008
Change of Share Registry
28-Nov-2008
Results of Annual General Meeting
28-Nov-2008
Annual General Meeting Presentation
7-Nov-2008
Appendix 3Z - Final Director`s Interest Notice
7-Nov-2008
Board Composition
31-Oct-2008
BMDI Tuta Reports Record Quarterly Sales
31-Oct-2008
Appendix 4C - Quarterly Report
30-Oct-2008
Nomination of Auditor
30-Oct-2008
Correction to Notice of Annual General Meeting
29-Oct-2008
Annual Report 2008
29-Oct-2008
Notice of Annual General Meeting
16-Oct-2008
Change of Address Details
16-Oct-2008
Resignation of Nightingale and Appointment of Mitchell
1-Oct-2008
Full Year Statutory Accounts
29-Aug-2008
Preliminary Final Report
14-Aug-2008
Details of Company Address
4-Aug-2008
Response to ASX Appendix 4C Query
31-Jul-2008
Change in substantial holding
30-Jul-2008
Appendix 4C - quarterly
10-Jul-2008
Change of Director`s Interest Notice
8-Jul-2008
Change of Director`s Interest Notice
27-Jun-2008
Final Director`s Interest Notice
26-Jun-2008
Passing away of Chairman Keith Cadell
23-Jun-2008
Change of Director`s Interest Notice
11-Jun-2008
Change of Director`s Interest Notice
23-May-2008
Becoming a substantial holder
15-May-2008
Change of Director`s Interest Notice
7-May-2008
Becoming a substantial holder
28-Apr-2008
Appendix 4C - quarterly
28-Apr-2008
Resignation of a Director and Appendix 3Z
28-Apr-2008
Change of Director`s Interest Notice
18-Apr-2008
Change of Director`s Interest Notice
7-Apr-2008
Appointment of a Director
2-Apr-2008
Change in substantial holding
31-Mar-2008
Appendix 3B
28-Mar-2008
Results of General Meeting
28-Mar-2008
Presentation to General Meeting
12-Mar-2008
Change in substantial holding
11-Mar-2008
Shareholders` Meeting to Approve the TUTA Acquisition
29-Feb-2008
Half Yearly Report and Accounts
14-Feb-2008
TUTA Healthcare Acquisition and $1.0M Underwritten Placement
30-Jan-2008
Appendix 4C - quarterly
11-Dec-2007
Change in substantial holding
11-Dec-2007
Appendix 3B
5-Dec-2007
Activities Update
15-Nov-2007
Change in substantial holding
30-Oct-2007
Results of AGM
30-Oct-2007
Presentation to AGM
29-Oct-2007
Appendix 4C - quarterly
11-Oct-2007
Product Launch int the UK and Eurpoe
27-Sep-2007
30 June 2007 Annual Report and Notice of AGM
31-Aug-2007
Preliminary Final Report
31-Jul-2007
Appendix 4C - quarterly
30-Jul-2007
USA FDA Registration for IMD Safety Syringes
26-Jul-2007
Company Activity Update
25-Jul-2007
Change of Director`s Interest Notice
23-Jul-2007
Change in substantial holding
2-Jul-2007
Change in substantial holding
22-May-2007
Change of Director's Interest Notice
27-Apr-2007
Change in substantial holding
27-Apr-2007
Appendix 3B
26-Apr-2007
Commitments Test Entity - Third Quarter Report
20-Apr-2007
Change of Director's Interest Notice
19-Apr-2007
Change of Director's Interest Notice
1-Mar-2007
Appointment of Managing Director
27-Feb-2007
Half Yearly Report & Half Year Accounts
9-Feb-2007
Becoming a substantial holder
7-Feb-2007
Commercial Ready Grant
7-Feb-2007
Change of Director's Interest Notice
6-Feb-2007
Becoming a substantial holder
2-Feb-2007
Becoming a substantial holder
2-Feb-2007
Becoming a substantial holder
31-Jan-2007
Change of Director's Interest Notice
30-Jan-2007
Commitments Test Entity - Second Quarter Report
21-Dec-2006
Appendix 3B
6-Dec-2006
Release of Escrow Shares
24-Nov-2006
Results of Meeting
24-Nov-2006
Presentation to AGM
24-Nov-2006
Director Appointment/Appendix 3X
31-Oct-2006
Response to ASX Query re: Appendix 4C
23-Oct-2006
Commitments Test Entity - First Quarter Report
28-Sep-2006
30 June 2006 Annual Report and Notice of AGM/Proxy Form
13-Sep-2006
Preliminary Final Report
11-Sep-2006
Supply Agreement with Terumo Corporation
27-Jul-2006
Long Term Contract with UNICEF
21-Jul-2006
Commitments Test Entity - Fourth Quarter Report
27-Jun-2006
Agreement with USA Medical devices Company
27-Jun-2006
Change of Director's Interest Notice x 2
21-Jun-2006
Appendix 3B
18-May-2006
Details of IMD Group Limited Share Purchase Plan
17-May-2006
Commercialisation of Auto Retractable Syringe
11-May-2006
Share Purchase Plan
11-May-2006
Appendix 3B
27-Apr-2006
Commitments Test Entity - Third Quarter Report
18-Apr-2006
First USA and European Sales & Appointment of Distributors
15-Mar-2006
Half Year Accounts
7-Mar-2006
Half Yearly Report
2-Mar-2006
TGA Approval for Manual Retractable Safety Syringe
17-Feb-2006
Director Resignation & Appointment/Appendix 3Z/3X
31-Jan-2006
Commitments Test Entity - Second Quarter Report
20-Dec-2005
Director Resignation
4-Nov-2005
Results of Meeting
4-Nov-2005
Presentation to AGM
28-Oct-2005
Commitments Test Entity - First Quarter Report
10-Oct-2005
Secures first Middle East Order of Medical Consumables
29-Sep-2005
Annual Report and Notice of AGM
28-Sep-2005
Appendix 3B
13-Sep-2005
Preliminary Final Report - Appendix 4E 30 June 2005
12-Sep-2005
Release of Escrow Shares
29-Jul-2005
Commitments Test Entity - Fourth Quarter Report
14-Jul-2005
Response to ASX Query re Share Price
31-May-2005
Succession of General Manager to CEO
13-May-2005
Letter to Shareholders: Update
6-May-2005
Expansion of Product Range & TGA Approval
5-May-2005
Australian Distribution Agreement
26-Apr-2005
Commitments Test Entity - Third Quarter Report
28-Feb-2005
Product Sales in India
25-Feb-2005
Half Year Accounts
25-Feb-2005
Half Yearly Report
11-Feb-2005
Expansion of Safety Syringe Product Range
7-Feb-2005
Canadian Regulatory Approval
3-Feb-2005
Chinese Distribution Agreement
31-Jan-2005
Commitments Test Entity - Second Quarter Report
18-Jan-2005
TGA Approval
22-Dec-2004
Initial Director's Interest Notice x4
20-Dec-2004
Expansion of FDA & CE Mark approved product range
17-Dec-2004
Investigation Accountant's Rep-Pro Forma Historical Fin Info
17-Dec-2004
Top 20 shareholders/Reviewed Pro forma Balance Sheet
17-Dec-2004
Distribution Schedule
17-Dec-2004
Market Release: Pre-Quotation Disclosure
17-Dec-2004
Commencement of Official Quotation
17-Dec-2004
Admission to Official List
17-Dec-2004
Constitution
17-Dec-2004
Appendix 1A - ASX Listing application & agreement
10-Dec-2004
Disclosure Document